Application of 3D Printing Guide Plate in Dorsal Root Ganglion Intervention Treatments

August 2, 2022 updated by: Peking University Third Hospital

Application of 3D Printing Guide Plate in Transforaminal Epidural Steroid Injection (TFESI) Combined With Pulsed Radiofrequency (PRF) Treatment

This study applies 3D-printed customized guide plate in assisting the accurate puncture in transforaminal epidural steroid injection (TFESI) combined with pulsed radiofrequency (PRF) treatment. This technique can shorten reduce the intra-operative radiation, and do not affect the surgical outcome.

Study Overview

Detailed Description

Lumbar disc herniation (LDH) is a common degenerative spine disease and it can cause low back pain and lumbosacral radicular pain (LSRP). Transforaminal epidural steroid injection (TFESI) is one of the most common minimally invasive interventions for the treatment of LDH. TFESI combined with dorsal root ganglion pulsed radiofrequency (PRF) is an effective procedure for treating LSRP. Needle Puncture is the key technology in this procedure.

In the past when there were no customized guides, the surgeons would place the needle according to his/her previous experience under the guidance of C-arm fluoroscopy or CT. If the position of the needles is not satisfactory, repeated procedure will be performed. This would lead to an increase in the duration of surgery and intra-operative radiation, which is detrimental to both the surgeon and the patient. This problem is well solved by applying the 3D printing guide plate.

The application procedure for the the 3D printing guide plate: the model of the spine is established according to the patient's CT scan data to prepare the customized guide plate, then sterilize them for future use. The final position of needle is confirmed by C-arm fluoroscopy or CT.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Shuiqing Li, MD
  • Phone Number: +86(010)82265026
  • Email: bjfdfx@126.com

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • Recruiting
        • Pain medicine center of Peking University Third Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age ≥18 years old,
  2. Chronic lumbosacral radicular pain lasting ≥12 weeks,
  3. Dominant leg pain with less intense back pain,
  4. The previous failure of conservative management such as physiotherapy, exercise therapy, or analgesic medications,
  5. Pain intensity≥4 out of 10 on the numerical rating scale (NRS),
  6. Segmental pain of a radicular nature originating from the lumbar segments and with a shooting or lancinating quality corresponding to a dermatome suggestive of the involved nerve root,
  7. Availability of computed tomography/magnetic resonance imaging findings of pathology concordant with the side and level of their clinical features.

Exclusion Criteria:

  1. Patient refusal to participate in the study,
  2. Pregnant or nursing
  3. Progressive motor weakness in the affected leg,
  4. Allergies to local anesthetics, contrast dyes or steroids
  5. Significant anatomic deformity (either congenital or acquired) making it difficult to access the foramen as evidenced by computed tomography/magnetic resonance imaging
  6. Presence of cancer accounting for back pain
  7. Patients with platelet dysfunction, bleeding disorder or continuing anticoagulant treatment
  8. Steroid injection within the previous 12 weeks,
  9. Systemic infection,
  10. Injection site infection,
  11. Unstable medical or psychiatric condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 3D printing guide plate group
3D-printed customized guide plate will be used to guide the puncture in TFESI combined with dorsal root ganglion PRF.
3D-printed customized guide plate will be used to guide the puncture in TFESI combined with dorsal root ganglion PRF to help to reduce intra-operative radiation.
Active Comparator: Conventional guidance group
The surgeons would place the needle according to his/her previous experience under the guidance of C-arm fluoroscopy.
The surgeons would place the needle according to his/her previous experience under the guidance of C-arm fluoroscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
C-arm fluoroscopy times
Time Frame: Intraoperative
Numbers of using C-arm fluoroscopy
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Puncture time
Time Frame: Intraoperative
Time from the first puncture to the last puncture
Intraoperative
Complications
Time Frame: Intraoperative
Complication like nerve injury, blood, hemotoma, etc.
Intraoperative
Numerical rating scale (NRS)
Time Frame: Postoperative 1 day, 1 month, 3 months
NRS at One day, 1 month, 3 months after the operation
Postoperative 1 day, 1 month, 3 months
MacNab
Time Frame: Postoperative 3 months
Patient satisfaction using the modified MacNab criteria
Postoperative 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 8, 2022

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

May 30, 2022

First Submitted That Met QC Criteria

May 30, 2022

First Posted (Actual)

June 3, 2022

Study Record Updates

Last Update Posted (Actual)

August 3, 2022

Last Update Submitted That Met QC Criteria

August 2, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Disc Herniation

Clinical Trials on 3D printing guide plate

3
Subscribe